Guyana’s capacity to detect and monitor infectious diseases has received a boost, with the National Public Health Reference Laboratory (NPHRL) successfully achieving re-certification, reaffirming its commitment to maintaining quality and reliability in diagnostic services.
The achievement underscores the laboratory’s continued adherence to established quality management standards.
This is essential to ensuring accurate testing, supporting disease surveillance and strengthening the country’s response to public health threats.
The NPHRL plays a critical role in Guyana’s healthcare system, conducting diagnostic testing for diseases including HIV, hepatitis B and C, dengue and leptospirosis.
Its services provide important information that supports medical professionals in making informed treatment decisions while helping health authorities monitor disease trends and identify potential outbreaks.
The laboratory was initially certified by the Guyana National Bureau of Standards (GNBS) in October 2024, which sets out general requirements for laboratory operations.
Additionally, in January 2025, the facility received recognition from the Pan American Health Organization/World Health Organisation as a National Influenza Centre, strengthening Guyana’s participation in international influenza surveillance.
These developments form part of broader efforts to strengthen the country’s healthcare infrastructure and ensure that public health institutions are equipped to provide dependable services.
Through continued investment in technical capacity, quality assurance and disease monitoring, Guyana is working to build a more responsive and resilient public health system that safeguards the well-being of its population.
DPI
